Tocilizumab Preserves Lung Function in Early Systemic Sclerosis

FRIDAY, April 23, 2021 -- Tocilizumab prevents progression of interstitial lung disease in patients with early systemic sclerosis (SSc), according to a study recently published in Arthritis& Rheumatology. David Roofeh, M.D., from the...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news